Kedrion Biopharma - Keep Life Flowing

KEEP LIFE FLOWING

Kedrion’s plasma-derived therapies help people suffering from rare diseases like Hemophilia and Primary Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.
KEEP LIFE FLOWING

Kedrion’s plasma-derived therapies help people suffering from rare diseases like Hemophilia and Primary Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.
KEEP LIFE FLOWING

Kedrion’s plasma-derived therapies help people suffering from rare diseases like Hemophilia and Primary Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

News

The world of Kedrion Biopharma at a glance:
discover the latest
up-to-date news.

All news.

01-07-2024

Kedrion selected by Biotest to distribute its Immunoglobulin Yimmugo® in the U.S.

29-04-2024

Kedrion Announces Rare Disease Medicine RYPLAZIM® Now Available in the United States

Distribution resumes of first and only medicine to treatplasminogen deficiency type 1

24-04-2024

Kedrion Presents Advancements in Ultra-Rare Bleeding Disorders Research

At World Federation of Hemophilia Congress

KEEP LIFE FLOWING